Toxoplasmosis, unspecified
ICD-10 B68.9 is a billable code used to indicate a diagnosis of toxoplasmosis, unspecified.
Toxoplasmosis is an infection caused by the parasite Toxoplasma gondii, which can infect most warm-blooded animals, including humans. The infection is often asymptomatic in healthy individuals but can lead to severe complications in immunocompromised patients, such as those with HIV/AIDS or undergoing chemotherapy. In pregnant women, it poses a risk of congenital transmission, potentially resulting in serious fetal complications. The disease is typically acquired through ingestion of oocysts found in cat feces, contaminated food, or water, or through consumption of undercooked meat containing tissue cysts. Symptoms, when present, may include flu-like manifestations, lymphadenopathy, and ocular issues. Diagnosis is primarily through serological testing for specific antibodies or PCR testing. Treatment usually involves antiparasitic medications such as pyrimethamine and sulfadiazine, particularly in severe cases or in immunocompromised patients. The unspecified nature of this code indicates that the specific manifestations or complications of the infection are not detailed, which may complicate treatment and management.
Detailed clinical history, laboratory results, and treatment plans.
Patients presenting with flu-like symptoms, immunocompromised patients, and pregnant women.
Need for thorough documentation of serological tests and any complications.
Pregnancy status, serological testing results, and fetal monitoring.
Pregnant women with potential exposure to Toxoplasma.
Documentation of maternal and fetal health outcomes.
Used to confirm diagnosis in suspected cases of toxoplasmosis.
Document the reason for testing and results.
Infectious disease specialists should ensure comprehensive testing.
Common symptoms include flu-like symptoms, lymphadenopathy, and in severe cases, neurological symptoms or ocular issues.
Diagnosis is typically made through serological testing for antibodies against Toxoplasma gondii, with PCR testing used in severe cases.
Treatment usually involves antiparasitic medications such as pyrimethamine and sulfadiazine, especially in severe cases or in immunocompromised patients.
